Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2401 Elliott Avenue, Suite 320, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Former names
IsoRay, Inc. (to 2/16/2023), Isoray, Inc. (to 2/16/2023), CENTURY PARK PICTURES CORP (to 8/3/2005)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.12K % +105%
Quick Ratio 18.2 % -64.6%
Debt-to-equity 18.3 % +92%
Return On Equity -26.2 % +0.87%
Return On Assets -22.1 % +8.25%
Operating Margin -93.7 % -91.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.6M shares -75.9%
Common Stock, Shares, Outstanding 67.6M shares -75.9%
Entity Public Float 186M USD +328%
Common Stock, Value, Issued 67K USD -76.2%
Weighted Average Number of Shares Outstanding, Basic 70.6M shares +152%
Weighted Average Number of Shares Outstanding, Diluted 70.6M shares +152%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.19M USD +27.3%
Research and Development Expense 35.8M USD +174%
Selling and Marketing Expense 855K USD +6.88%
General and Administrative Expense 23.3M USD +34.5%
Operating Income (Loss) -57.6M USD -90.4%
Nonoperating Income (Expense) 7.77M USD +536%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -49.8M USD -71.6%
Income Tax Expense (Benefit) -2.65M USD
Net Income (Loss) Attributable to Parent -63.8M USD -154%
Earnings Per Share, Basic 0.19 USD/shares +43.2%
Earnings Per Share, Diluted -0.21 USD/shares +43.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 226M USD +1159%
Cash, Cash Equivalents, and Short-term Investments 268M USD
Accounts Receivable, after Allowance for Credit Loss, Current 217K USD -87.5%
Inventory, Net 1.01M USD -34.8%
Other Assets, Current 45K USD
Assets, Current 270M USD +1146%
Property, Plant and Equipment, Net 43.8M USD +525%
Operating Lease, Right-of-Use Asset 2.43M USD +59.1%
Intangible Assets, Net (Excluding Goodwill) 354K USD
Goodwill 24.1M USD -11.9%
Other Assets, Noncurrent 694K USD +26%
Assets 391M USD +254%
Employee-related Liabilities, Current 3.98M USD
Liabilities, Current 28.1M USD +247%
Deferred Income Tax Liabilities, Net 4.59M USD
Operating Lease, Liability, Noncurrent 1.68M USD +31.3%
Other Liabilities, Noncurrent 33K USD
Liabilities 62.7M USD +434%
Retained Earnings (Accumulated Deficit) -192M USD -49.9%
Stockholders' Equity Attributable to Parent 328M USD +233%
Liabilities and Equity 391M USD +254%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 13.8M USD
Net Cash Provided by (Used in) Financing Activities 166M USD
Net Cash Provided by (Used in) Investing Activities -47.3M USD -287%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 67.6M shares -75.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD +760%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.1M USD -9.13%
Deferred Tax Assets, Valuation Allowance 30M USD +45.4%
Deferred Tax Assets, Gross 38.8M USD +88.6%
Operating Lease, Liability 2.58M USD +64.4%
Depreciation 346K USD +92.2%
Payments to Acquire Property, Plant, and Equipment 9.07M USD +4413%
Lessee, Operating Lease, Liability, to be Paid 2.94M USD +57.8%
Property, Plant and Equipment, Gross 46M USD +201%
Operating Lease, Liability, Current 903K USD +208%
Lessee, Operating Lease, Liability, to be Paid, Year Two 647K USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.11M USD +159%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 7.85M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 361K USD +22.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 493K USD +42.9%
Deferred Tax Assets, Operating Loss Carryforwards 26.8M USD +39.8%
Preferred Stock, Shares Authorized 7M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 443K USD +92.6%
Deferred Tax Assets, Net of Valuation Allowance 11K USD
Share-based Payment Arrangement, Expense 3.85M USD +367%
Interest Expense 84 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%